Sfoglia per Autore
The unbearable underreporting of comorbidities in heart failure clinical trials
2020-01-01 Aimo, A.; Barison, A.; Castiglione, V.; Emdin, M.
Molecular autopsy of sudden cardiac death in the genomics era
2021-01-01 Castiglione, V.; Modena, M.; Aimo, A.; Chiti, E.; Botto, N.; Vittorini, S.; Guidi, B.; Vergaro, G.; Barison, A.; Rossi, A.; Passino, C.; Giannoni, A.; Di Paolo, M.; Emdin, M.
Biomarkers for the diagnosis and management of heart failure
2021-01-01 Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M.
A simple echocardiographic score to rule out cardiac amyloidosis
2021-01-01 Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
2021-01-01 Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.
The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis?
2021-01-01 Aimo, A.; Castiglione, V.; Barison, A.; Chubuchnyi, V.; Emdin, M.
Coronary Artery Anomalies
2021-01-01 Gentile, F.; Castiglione, V.; De Caterina, R.
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
2021-01-01 Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M.
Biomarkers for the diagnosis and management of heart failure: New frontiers
2021-01-01 Vergaro, G.; Castiglione, V.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Giannelli, E.; Maltinti, M.; Passino, C.; Emdin, M.
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides
2021-01-01 Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure
2021-01-01 Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
2021-01-01 Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M.
Use of biomarkers to diagnose and manage cardiac amyloidosis
2021-01-01 Castiglione, V.; Franzini, M.; Aimo, A.; Carecci, A.; Lombardi, C. M.; Passino, C.; Rapezzi, C.; Emdin, M.; Vergaro, G.
Current and emerging drug targets in heart failure treatment
2021-01-01 Ghionzoli, N.; Gentile, F.; Del Franco, A. M.; Castiglione, V.; Aimo, A.; Giannoni, A.; Burchielli, S.; Cameli, M.; Emdin, M.; Vergaro, G.
RNA-targeting and gene editing therapies for transthyretin amyloidosis
2022-01-01 Aimo, Alberto; Castiglione, Vincenzo; Rapezzi, Claudio; Franzini, Maria; Panichella, Giorgia; Vergaro, Giuseppe; Gillmore, Julian; Fontana, Marianna; Passino, Claudio; Emdin, Michele
Targeting precipitants to prevent heart failure hospitalization. Does season matter?
2022-01-01 Castiglione, Vincenzo; Vergaro, Giuseppe; Emdin, Michele
Atrial amyloidosis: mechanisms and clinical manifestations
2022-01-01 Vergaro, G.; Aimo, A.; Rapezzi, C.; Castiglione, V.; Fabiani, I.; Pucci, A.; Buda, G.; Passino, C.; Lupon, J.; Bayes-Genis, A.; Emdin, M.; Braunwald, E.
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is
2022-01-01 Emdin, Michele; Aimo, Alberto; Castiglione, Vincenzo
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning
2022-01-01 Quattrone, F.; Aimo, A.; Castiglione, V.; Passino, C.; Bergamasco, M.; Barsanti, S.; Nuti, S.; Emdin, M.
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis
2022-01-01 Aimo, Alberto; Fabiani, Iacopo; Giannoni, Alberto; Mandoli, Giulia Elena; Pastore, Maria Concetta; Vergaro, Giuseppe; Spini, Valentina; Chubuchny, Vladyslav; Pasanisi, Emilio Maria; Petersen, Christina; Poggianti, Elisa; Taddei, Claudia; Castiglione, Vincenzo; Latrofa, Sara; Panichella, Giorgia; Sciaccaluga, Carlotta; Georgiopoulos, Georgios; Passino, Claudio; Cameli, Matteo; Emdin, Michele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The unbearable underreporting of comorbidities in heart failure clinical trials | 1-gen-2020 | Aimo, A.; Barison, A.; Castiglione, V.; Emdin, M. | |
| Molecular autopsy of sudden cardiac death in the genomics era | 1-gen-2021 | Castiglione, V.; Modena, M.; Aimo, A.; Chiti, E.; Botto, N.; Vittorini, S.; Guidi, B.; Vergaro, G.; Barison, A.; Rossi, A.; Passino, C.; Giannoni, A.; Di Paolo, M.; Emdin, M. | |
| Biomarkers for the diagnosis and management of heart failure | 1-gen-2021 | Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M. | |
| A simple echocardiographic score to rule out cardiac amyloidosis | 1-gen-2021 | Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M. | |
| Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient | 1-gen-2021 | Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M. | |
| The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis? | 1-gen-2021 | Aimo, A.; Castiglione, V.; Barison, A.; Chubuchnyi, V.; Emdin, M. | |
| Coronary Artery Anomalies | 1-gen-2021 | Gentile, F.; Castiglione, V.; De Caterina, R. | |
| Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets | 1-gen-2021 | Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M. | |
| Biomarkers for the diagnosis and management of heart failure: New frontiers | 1-gen-2021 | Vergaro, G.; Castiglione, V.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Giannelli, E.; Maltinti, M.; Passino, C.; Emdin, M. | |
| Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides | 1-gen-2021 | Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C. | |
| Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure | 1-gen-2021 | Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C. | |
| The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction | 1-gen-2021 | Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M. | |
| Use of biomarkers to diagnose and manage cardiac amyloidosis | 1-gen-2021 | Castiglione, V.; Franzini, M.; Aimo, A.; Carecci, A.; Lombardi, C. M.; Passino, C.; Rapezzi, C.; Emdin, M.; Vergaro, G. | |
| Current and emerging drug targets in heart failure treatment | 1-gen-2021 | Ghionzoli, N.; Gentile, F.; Del Franco, A. M.; Castiglione, V.; Aimo, A.; Giannoni, A.; Burchielli, S.; Cameli, M.; Emdin, M.; Vergaro, G. | |
| RNA-targeting and gene editing therapies for transthyretin amyloidosis | 1-gen-2022 | Aimo, Alberto; Castiglione, Vincenzo; Rapezzi, Claudio; Franzini, Maria; Panichella, Giorgia; Vergaro, Giuseppe; Gillmore, Julian; Fontana, Marianna; Passino, Claudio; Emdin, Michele | |
| Targeting precipitants to prevent heart failure hospitalization. Does season matter? | 1-gen-2022 | Castiglione, Vincenzo; Vergaro, Giuseppe; Emdin, Michele | |
| Atrial amyloidosis: mechanisms and clinical manifestations | 1-gen-2022 | Vergaro, G.; Aimo, A.; Rapezzi, C.; Castiglione, V.; Fabiani, I.; Pucci, A.; Buda, G.; Passino, C.; Lupon, J.; Bayes-Genis, A.; Emdin, M.; Braunwald, E. | |
| Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is | 1-gen-2022 | Emdin, Michele; Aimo, Alberto; Castiglione, Vincenzo | |
| Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning | 1-gen-2022 | Quattrone, F.; Aimo, A.; Castiglione, V.; Passino, C.; Bergamasco, M.; Barsanti, S.; Nuti, S.; Emdin, M. | |
| Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis | 1-gen-2022 | Aimo, Alberto; Fabiani, Iacopo; Giannoni, Alberto; Mandoli, Giulia Elena; Pastore, Maria Concetta; Vergaro, Giuseppe; Spini, Valentina; Chubuchny, Vladyslav; Pasanisi, Emilio Maria; Petersen, Christina; Poggianti, Elisa; Taddei, Claudia; Castiglione, Vincenzo; Latrofa, Sara; Panichella, Giorgia; Sciaccaluga, Carlotta; Georgiopoulos, Georgios; Passino, Claudio; Cameli, Matteo; Emdin, Michele |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile